Wave Life Sciences Ltd.
Clinical trials sponsored by Wave Life Sciences Ltd., explained in plain language.
-
Experimental drug aims to restore muscle protein in boys with devastating muscle disease
Disease control Recruiting nowThis study is testing an investigational drug called WVE-N531 for boys and young men with Duchenne muscular dystrophy (DMD) who have a specific genetic mutation. The goal is to see if the drug is safe and if it can increase levels of a crucial muscle protein called dystrophin, wh…
Phase: PHASE1, PHASE2 • Sponsor: Wave Life Sciences Ltd. • Aim: Disease control
Last updated Apr 03, 2026 23:50 UTC
-
First human tests begin for new genetic disease therapy
Disease control Recruiting nowThis early-stage study is testing a new drug called WVE-006 for people with Alpha-1 Antitrypsin Deficiency (AATD), a genetic condition that can damage the lungs and liver. Researchers will give the drug to 24 participants to first check if it's safe and how the body handles it. T…
Phase: PHASE1, PHASE2 • Sponsor: Wave Life Sciences Ltd. • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
First human test for new obesity injection begins
Disease control Recruiting nowThis is a first-in-human study to test the safety and effects of an experimental drug called WVE-007 in adults with overweight or obesity. The drug is given as an injection under the skin. The main goal is to see how well the body tolerates it and how it behaves in the bloodstrea…
Phase: PHASE1 • Sponsor: Wave Life Sciences Ltd. • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC